share_log

康哲藥業:截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 1 04:00
Summary by Moomoo AI
康哲藥業控股有限公司於2024年2月29日向香港交易及結算所有限公司提交了新的證券變動月報表。報告顯示,截至2024年2月底,公司的法定/註冊股本結存維持在20,000,000,000股,每股面值0.005美元,總額100,000,000美元,本月無增減變動。已發行股份的結存數量亦未見變化。報告中確認,公司在本月內發行的證券已獲得董事會的正式授權,並符合香港聯合交易所有限公司證券上市規則的所有相關要求。公司秘書吳三燕於2024年3月1日呈交了該報表。
康哲藥業控股有限公司於2024年2月29日向香港交易及結算所有限公司提交了新的證券變動月報表。報告顯示,截至2024年2月底,公司的法定/註冊股本結存維持在20,000,000,000股,每股面值0.005美元,總額100,000,000美元,本月無增減變動。已發行股份的結存數量亦未見變化。報告中確認,公司在本月內發行的證券已獲得董事會的正式授權,並符合香港聯合交易所有限公司證券上市規則的所有相關要求。公司秘書吳三燕於2024年3月1日呈交了該報表。
CONGE PHARMACEUTICAL HOLDINGS LIMITED FILED A NEW MONTHLY STATEMENT OF CHANGES IN SECURITIES WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED ON 29 FEBRUARY 2024. The report shows that as of the end of February 2024, the company's regulated/registered share capital remained at 20,000,000,000 shares with a face value of $0.005 per share for a total of $100,000,000, unchanged this month. There was no change in the number of deposits of issued shares. The report confirms that the securities issued by the Company during this month have been formally authorized by the Board of Directors and comply with all relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited. Company Secretary Wu Sanyan submitted the report on 1 March 2024.
CONGE PHARMACEUTICAL HOLDINGS LIMITED FILED A NEW MONTHLY STATEMENT OF CHANGES IN SECURITIES WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED ON 29 FEBRUARY 2024. The report shows that as of the end of February 2024, the company's regulated/registered share capital remained at 20,000,000,000 shares with a face value of $0.005 per share for a total of $100,000,000, unchanged this month. There was no change in the number of deposits of issued shares. The report confirms that the securities issued by the Company during this month have been formally authorized by the Board of Directors and comply with all relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited. Company Secretary Wu Sanyan submitted the report on 1 March 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more